Modifying effect of hospital size on the impact of antimicrobial stewardship programs for methicillin-resistant Staphylococcus aureus bloodstream infections: a nationwide claims database analysis

The effectiveness of antimicrobial stewardship programs may vary by institutional context. We evaluated whether hospital size modifies the impact of nationally incentivized antimicrobial stewardship programs on clinical and economic outcomes in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. This retrospective cohort study analyzed Japanese nationwide claims data from 2018 to 2022. We compared outcomes between adult inpatients with methicillin-resistant Staphylococcus aureus bloodstream infections in large (≥ 500 beds) versus non-large (< 500 beds) hospitals using 1:1 propensity score matching. The primary outcome was time to discharge. We used an interaction term to assess effect modification by hospital size on the association between antimicrobial stewardship programs and outcomes. The matched cohort included 926 patients (463 pairs). At baseline, average daily total antimicrobial costs were significantly higher in large hospitals (rate ratio 1.32, 95% CI 1.16–1.50). Hospital size significantly modified the association between antimicrobial stewardship programs and time to discharge (P for interaction = 0.01). In non-large hospitals, antimicrobial stewardship programs were associated with significantly shorter time to discharge (hazard ratio 0.31, 95% CI 0.13–0.75). In large hospitals, antimicrobial stewardship programs were not associated with time to discharge but were associated with significantly reduced average daily antipseudomonal drug costs (rate ratio 0.46, 95% CI 0.30–0.71). Hospital size modified the association between antimicrobial stewardship program fee acquisition and outcomes among patients with methicillin-resistant Staphylococcus aureus bloodstream infections. In non-large hospitals, antimicrobial stewardship program fee acquisition was associated with shorter time to discharge, whereas in large hospitals, it was primarily associated with changes in prescribing patterns. These findings suggest that stewardship evaluation and policy should be tailored to institutional characteristics.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical Health Care and Sciences
Published
2026-02-26
DOI
https://doi.org/10.1186/s40780-026-00558-2
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modifying effect of hospital size on the impact of antimicrobial stewardship programs for methicillin-resistant Staphylococcus aureus bloodstream infections: a nationwide claims database analysis

Keisuke Sawada, Ryo Inose, Yuichi Muraki
Journal of Pharmaceutical Health Care and Sciences
Antimicrobial Resistance in Staphylococcus
article

Modifying effect of hospital size on the impact of antimicrobial stewardship programs for methicillin-resistant Staphylococcus aureus bloodstream infections: a nationwide claims database analysis

Keisuke Sawada, Ryo Inose, Yuichi Muraki
article en

Abstract

The effectiveness of antimicrobial stewardship programs may vary by institutional context. We evaluated whether hospital size modifies the impact of nationally incentivized antimicrobial stewardship programs on clinical and economic outcomes in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. This retrospective cohort study analyzed Japanese nationwide claims data from 2018 to 2022. We compared outcomes between adult inpatients with methicillin-resistant Staphylococcus aureus bloodstream infections in large (≥ 500 beds) versus non-large (< 500 beds) hospitals using 1:1 propensity score matching. The primary outcome was time to discharge. We used an interaction term to assess effect modification by hospital size on the association between antimicrobial stewardship programs and outcomes. The matched cohort included 926 patients (463 pairs). At baseline, average daily total antimicrobial costs were significantly higher in large hospitals (rate ratio 1.32, 95% CI 1.16–1.50). Hospital size significantly modified the association between antimicrobial stewardship programs and time to discharge (P for interaction = 0.01). In non-large hospitals, antimicrobial stewardship programs were associated with significantly shorter time to discharge (hazard ratio 0.31, 95% CI 0.13–0.75). In large hospitals, antimicrobial stewardship programs were not associated with time to discharge but were associated with significantly reduced average daily antipseudomonal drug costs (rate ratio 0.46, 95% CI 0.30–0.71). Hospital size modified the association between antimicrobial stewardship program fee acquisition and outcomes among patients with methicillin-resistant Staphylococcus aureus bloodstream infections. In non-large hospitals, antimicrobial stewardship program fee acquisition was associated with shorter time to discharge, whereas in large hospitals, it was primarily associated with changes in prescribing patterns. These findings suggest that stewardship evaluation and policy should be tailored to institutional characteristics.

Journal of Pharmaceutical Health Care and Sciences
Kyoto Pharmaceutical University (JP), Municipal Hirakata City Hospital (JP)
Openalex Percentile: Top 43%
Antimicrobial Resistance in Staphylococcus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.